Get the Stockscreener App
0.5284
1.40%
-0.0075
Rani Therapeutics Holdings Inc stock is traded at $0.5284, with a volume of 604.02K.
It is down -1.40% in the last 24 hours and up +2.90% over the past month.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
See More
Previous Close:
$0.5359
Open:
$0.5272
24h Volume:
604.02K
Relative Volume:
0.34
Market Cap:
$20.73M
Revenue:
$3.04M
Net Income/Loss:
$-33.97M
P/E Ratio:
-0.3973
EPS:
-1.33
Net Cash Flow:
$-52.47M
1W Performance:
-0.68%
1M Performance:
+2.90%
6M Performance:
-61.99%
1Y Performance:
-80.57%
1-Day Range:
$0.5164
$0.5426
1-Week Range:
$0.51
$0.5886
52-Week Range:
$0.387
$3.75
Rani Therapeutics Holdings Inc Stock (RANI) Company Profile
Name
Rani Therapeutics Holdings Inc
Sector
Industry
Phone
(408) 457-3700
Address
2051 RINGWOOD AVENUE, SAN JOSE
Compare RANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RANI
Rani Therapeutics Holdings Inc
|
0.5284 | 23.36M | 3.04M | -33.97M | -52.47M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-02-24 | Initiated | Oppenheimer | Outperform |
| Jun-14-24 | Initiated | Maxim Group | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-17-23 | Resumed | BTIG Research | Buy |
| Oct-11-22 | Initiated | UBS | Buy |
| Jul-27-22 | Initiated | H.C. Wainwright | Buy |
| Jun-13-22 | Initiated | Wedbush | Outperform |
View All
Rani Therapeutics Holdings Inc Stock (RANI) Latest News
Is Rani Therapeutics Holdings Inc. trending in predictive chart modelsHigh Reward Investment Strategy for Beginners - Newser
What makes Rani Therapeutics Holdings Inc. stock price move sharplyFree Investment Plan With Growth Optimization - Newser
Will Rani Therapeutics Holdings Inc. benefit from macro trendsMarket Liquidity and Price Flow Analysis - Newser
Ranking Rani Therapeutics Holdings Inc. among high performing stocks via toolsForecasting Stock Moves with AI Insights - Newser
How does Rani Therapeutics Holdings Inc. generate profit in a changing economyExpert Picks Tips With Proven Results - jammulinksnews.com
Why Rani Therapeutics Holdings Inc. stock attracts strong analyst attentionForecast Model for Intraday Buy Signals - Newser
What momentum shifts mean for Rani Therapeutics Holdings Inc.Equity Forecast with Predictive AI Screener - Newser
What institutional investors are buying Rani Therapeutics Holdings Inc. stockBreakout Stocks Watchlist That Work - jammulinksnews.com
Visual analytics tools that track Rani Therapeutics Holdings Inc. performanceHigh Accuracy Trade Setup Identification - Newser
News impact scoring models applied to Rani Therapeutics Holdings Inc.Free Confirmed Setup With Expert Accuracy - Newser
Is Rani Therapeutics Holdings Inc. forming a bottoming basePrice Action Trading with Volume Confirmation - Newser
Sector ETF performance correlation with Rani Therapeutics Holdings Inc.Neural Network Based Equity Prediction System - Newser
Should I hold or sell Rani Therapeutics Holdings Inc. stock in 2025Beginner Investor Growth Plan Backed By Experts - jammulinksnews.com
What is Rani Therapeutics Holdings Inc. company’s growth strategyAI Powered Planner Backed By Experts - jammulinksnews.com
Is Rani Therapeutics Holdings Inc. stock reversal real or fakeEntry Confirmation Based on Volatility Analysis - Newser
Published on: 2025-07-31 00:35:11 - Newser
Does Rani Therapeutics Holdings Inc. show high probability of reboundPredictive AI Engine for Smart Investing - Newser
What technical models suggest about Rani Therapeutics Holdings Inc.’s comebackEntry Timing Tracker with Alert Accuracy - Newser
How Rani Therapeutics Holdings Inc. stock performs during market volatilityIntraday Signal Forecast for Fast Traders - Newser
Kestra Private Wealth Services LLC Grows Holdings in Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) - Defense World
Will Rani Therapeutics Holdings Inc. Stock Benefit from AI and Green Energy TrendsHigh Yield Signals with Entry Timing - Newser
How many analysts rate Rani Therapeutics Holdings Inc. as a “Buy”Consistent double returns - jammulinksnews.com
When is Rani Therapeutics Holdings Inc. stock expected to show significant growthUnlock exclusive stock market insights - jammulinksnews.com
What is the risk reward ratio of investing in Rani Therapeutics Holdings Inc. stockGet daily expert analysis on top stocks - jammulinksnews.com
How volatile is Rani Therapeutics Holdings Inc. stock compared to the marketLightning-fast capital gains - jammulinksnews.com
Published on: 2025-07-28 02:48:53 - jammulinksnews.com
What is the dividend policy of Rani Therapeutics Holdings Inc. stockGet real-time alerts on top stocks - jammulinksnews.com
Is it the right time to buy Rani Therapeutics Holdings Inc. stockSuperior stock growth - jammulinksnews.com
Does Rani Therapeutics Holdings Inc. stock perform well during market downturnsAchieve explosive financial results today - jammulinksnews.com
Rani Therapeutics Holdings Inc Stock (RANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rani Therapeutics Holdings Inc Stock (RANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Imran Talat | Chief Executive Officer |
Dec 09 '24 |
Buy |
1.94 |
10,296 |
19,974 |
494,751 |
| South Cone Investments Limited | 10% Owner |
Oct 15 '24 |
Sale |
2.65 |
3,829,360 |
10,141,674 |
8,302,194 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):